Get the Stockscreener App
37.70
3.70%
-1.45
Scholar Rock Holding Corp stock is traded at $37.70, with a volume of 711.02K.
It is down -3.70% in the last 24 hours and down -16.00% over the past month.
Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company operates in the United States. The company's product candidate is Apitegroma which is a selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Its other product comprises SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 ("TGFβ1"), for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies.
See More
Previous Close:
$39.15
Open:
$39.79
24h Volume:
711.02K
Relative Volume:
0.72
Market Cap:
$3.53B
Revenue:
$47.30M
Net Income/Loss:
$-225.97M
P/E Ratio:
-16.04
EPS:
-2.35
Net Cash Flow:
$-188.86M
1W Performance:
+1.70%
1M Performance:
-16.00%
6M Performance:
+307.13%
1Y Performance:
+151.67%
1-Day Range:
$37.65
$40.18
1-Week Range:
$35.34
$40.18
52-Week Range:
$6.76
$46.98
Scholar Rock Holding Corp Stock (SRRK) Company Profile
Name
Scholar Rock Holding Corp
Sector
Industry
Phone
857-259-3860
Address
301 BINNEY STREET, CAMBRIDGE, MA
Compare SRRK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRRK
Scholar Rock Holding Corp
|
37.70 | 3.53B | 47.30M | -225.97M | -188.86M | -2.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-26-24 | Reiterated | H.C. Wainwright | Buy |
| Oct-07-24 | Reiterated | H.C. Wainwright | Buy |
| Mar-28-24 | Initiated | Raymond James | Strong Buy |
| Oct-25-23 | Upgrade | Jefferies | Hold → Buy |
| Apr-03-23 | Resumed | Piper Sandler | Overweight |
| Sep-19-22 | Resumed | H.C. Wainwright | Buy |
| Jul-12-22 | Initiated | Truist | Buy |
| Mar-23-22 | Initiated | H.C. Wainwright | Buy |
| Dec-22-21 | Downgrade | Jefferies | Buy → Hold |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Jan-11-21 | Initiated | Credit Suisse | Outperform |
| Jan-06-21 | Initiated | JP Morgan | Overweight |
| Mar-12-20 | Initiated | Robert W. Baird | Outperform |
View All
Scholar Rock Holding Corp Stock (SRRK) Latest News
Scholar Rock Holding Co. (NASDAQ:SRRK) General Counsel Junlin Ho Sells 5,742 Shares - MarketBeat
Scholar Rock Holding Co. (NASDAQ:SRRK) CFO Edward H. Myles Sells 7,809 Shares - MarketBeat
Scholar Rock Holding Co. (NASDAQ:SRRK) Insider Mo Qatanani Sells 68,510 Shares - MarketBeat
Scholar Rock (SRRK) Expected to Announce Earnings on Thursday - Defense World
Scholar Rock's chief scientific officer sells shares worth $2.56 million By Investing.com - Investing.com South Africa
Scholar Rock's chief scientific officer sells shares worth $2.56 million - Investing.com
Scholar Rock's general counsel Junlin Ho sells $211,472 in stock - Investing.com India
Scholar Rock Executives Sell Shares to Cover Tax Obligations - TradingView
Scholar Rock CFO Caryn Parlavecchio sells shares worth $195,046 - Investing.com
Scholar rock's COO & CFO Myles Edward H sells $287,597 in shares - Investing.com
Scholar Rock CEO Jay T. Backstrom Sells Shares to Cover Tax Obligation - TradingView
Analysts Set Scholar Rock Holding Co. (NASDAQ:SRRK) Target Price at $40.43 - MarketBeat
Investors Take Advantage Of -0.32% Loss In Scholar Rock Holding Corp (NASDAQ: SRRK) - Stocks Register
Scholar Rock's chief commercial officer sells $171,927 in common stock - MSN
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)February 14, 2025 - BioSpace
SRRK Stock Soars to 52-Week High, Reaching $46.38 - MSN
Scholar Rock Holding Co. (NASDAQ:SRRK) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Scholar Rock Holding Co. (NASDAQ:SRRK) Stake Reduced by Values First Advisors Inc. - MarketBeat
Scholar Rock (NASDAQ:SRRK) Shares Gap DownHere's What Happened - MarketBeat
abrdn plc Has $6.15 Million Position in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Checking in on Frontier Communications Parent Inc (FYBR) after recent insiders movement - Knox Daily
Market Recap: Standard Lithium Ltd (SLI)’s Negative Momentum, Closing at 1.49 - The Dwinnex
Cantor Fitzgerald initates Zoom Communications Inc (ZM) rating to a Neutral - Knox Daily
Scholar Rock to Host Conference Call to Discuss Fourth Quarter and Full-Year 2024 Financial Results and Provide Business Update on February 27, 2025 - BioSpace
Scholar Rock (SRRK) Earnings Call: Key Updates on SMA Treatment Pipeline Coming Feb 27 - StockTitan
E. Ohman J or Asset Management AB Cuts Stake in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
KBC Group NV Buys Shares of 3,020 Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Scholar Rock Holding Corp (SRRK) requires closer examination - US Post News
Investor’s Delight: Scholar Rock Holding Corp (SRRK) Closes Weak at 40.05, Down -0.82 - The Dwinnex
Its Stock Has Paid Off Big Time For Scholar Rock Holding Corp - SETE News
Scholar Rock Holding Corp [SRRK] stock was sold by Backstrom Jay T. at the price of US$0.99 million - Knox Daily
A Guide To The Risks Of Investing In VNET Group Inc ADR (VNET) - Knox Daily
Scholar Rock (NASDAQ:SRRK) Trading Down 4.6%Time to Sell? - MarketBeat
Scholar Rock Announces Key Leadership ChangesOn January 29, 2025, Scholar Rock Holding Corporation (NASDAQ: SRRK) disclosed significant changes to its executive team in a recent 8-K filing with the Securities and Exchange Commission.Ms. Lisa Wy - Defense World
Scholar Rock's (SRRK) "Outperform" Rating Reaffirmed at Wedbush - MarketBeat
Exchange Traded Concepts LLC Sells 82,792 Shares of Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
SG Americas Securities LLC Has $938,000 Stock Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
27,786 Shares in Scholar Rock Holding Co. (NASDAQ:SRRK) Bought by Moody Aldrich Partners LLC - MarketBeat
Scholar Rock Holding Co. (NASDAQ:SRRK) Shares Acquired by Nisa Investment Advisors LLC - Defense World
JPMorgan Chase & Co. Grows Stock Position in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Scholar Rock (NASDAQ:SRRK) Earns Outperform Rating from Wedbush - Defense World
Wyman joins Scholar Rock - BioCentury
SG Americas Securities LLC Sells 114,797 Shares of Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Scholar Rock Submits Biologics License Application (BLA) to the U.S. FDA for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA) - sharewise
Scholar Rock Announces the Appointment of Industry Leader Lisa Wyman as Chief Technical and Quality Officer and Planned Leadership Transition - sharewise
Scholar Rock submits FDA application for SMA treatment - Investing.com India
Scholar Rock Names Lisa Wyman as Chief Technical, Quality Officer, COO Role to Be Eliminated - Marketscreener.com
Scholar Rock Holding Corp Stock (SRRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
3.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):